[Early insulin therapy in type 2 diabetes?].
Avdeling for endokrinologi, sykelig overvekt og forebyggende medisin, Oslo universitetssykehus, Norway. k.i.birkeland@medisin.uio.no
Kåre I
KI
Birkeland
D001786:Blood Glucose; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000517:prevention & control; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
D001786:Blood Glucose; D015525:Fatty Acids, Omega-3; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine